Influence of COVID-19 infection on placental function
, 2, 2
Abstract
Objectives: Pregnant women are more susceptible to infectious diseases because of their natural immunosuppression. SARS-CoV-2 seems to be a potential risk for the condition of women and the fetus. Unfortunately, knowledge of the influence of coronavirus disease 19 (COVID-19) on pregnant women and their children is still very limited, and further investigation and analysis are needed. The aim of the study was to conduct a meta-analysis of research about the impact of COVID-19 on the placenta.
Material and methods: Articles published between 2020 and 2021 and contained in the PubMed and Elsevier databases were analyzed.
Results: The SARS-CoV-2 infection also led to pregnancy complications in the patients. The most common pregnancy complications include caesarean delivery (80%), preterm delivery (26%), fetal distress (8%), premature rupture of the membranes (9%) and stillbirth (2%). Among the observed patients, neonatal complications occurred, such as premature delivery (25%), respiratory distress syndrome (8%), pneumonia (8%) and deaths of 4 newborns SARS-CoV-2 was found mainly in syncytiotrophoblast cells at the maternal-fetal border of the placenta. Histological examination of the placenta revealed dense macrophage infiltration. Abnormal perfusion of fetal blood vessels or fetal vascular thrombosis was observed. Elevated levels of SARS-CoV-2 IgG or IgM antibodies in the umbilical cord blood were observed in nine newborns, reported as evidence of vertical infection.
Conclusions: The features of placental damage in women with COVID-19 are clearly different from the control group. Further research is needed to better understand how SARS-CoV-2 infection affects the placenta.
Keywords: SARS-CoV-2 infectionplacentaCOVID-19 in pregnancyumbilical cord
References
- Li Q, Guan X, Wu P, et al. Early transmission dynamics in wuhan, china, of novel coronavirus-infected pneumonia. N Engl J Med. 2020; 382(13): 1199–1207.
- Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020; 181(2): 271–280.e8.
- Mor G, Cardenas I, Abrahams V, et al. Inflammation and pregnancy: the role of the immune system at the implantation site. Ann N Y Acad Sci. 2011; 1221(1): 80–87.
- Tang K, Gaoshan J, Ahonsi B, et al. Sexual and reproductive health (SRH): a key issue in the emergency response to the coronavirus disease (COVID- 19) outbreak. Reprod Health. 2020; 17(1): 59.
- Qiao J. What are the risks of COVID-19 infection in pregnant women? Lancet. 2020; 395(10226): 760–762.
- Liu Y, Chen H, Tang K, et al. Withdrawn: Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy. J Infect. 2020 [Epub ahead of print]: S0163–4453(20)30109-2..
- Burton GJ, Fowden AL. The placenta: a multifaceted, transient organ. Philos Trans R Soc Lond B Biol Sci. 2015; 370(1663): 20140066.
- Knöfler M, Pollheimer J. Human placental trophoblast invasion and differentiation: a particular focus on Wnt signaling. Front Genet. 2013; 4: 190.
- Ventura Ferreira MS, Bienert M, Müller K, et al. Comprehensive characterization of chorionic villi-derived mesenchymal stromal cells from human placenta. Stem Cell Res Ther. 2018; 9(1): 28.
- León-Juárez M, Martínez-Castillo M, González-García LD, et al. Cellular and molecular mechanisms of viral infection in the human placenta. Pathog Dis. 2017; 75(7): ftx093.
- Ghema K, Lehlimi M, Toumi H, et al. Outcomes of newborns to mothers with COVID-19. Infect Dis Now. 2021; 51(5): 435–439.
- Jaiswal N, Puri M, Agarwal K, et al. COVID-19 as an independent risk factor for subclinical placental dysfunction. Eur J Obstet Gynecol Reprod Biol. 2021; 259: 7–11.
- Gajbhiye R, Modi D, Mahale S. Pregnancy outcomes, Newborn complications and Maternal-Fetal Transmission of SARS-CoV-2 in women with COVID-19: A systematic review of 441 cases. medRxiv. 2020 [online Ahead of Print].
- Hosier H, Farhadian SF, Morotti RA, et al. SARS-CoV-2 infection of the placenta. J Clin Invest. 2020; 130(9): 4947–4953.
- Shanes ED, Mithal LB, Otero S, et al. Placental pathology in COVID-19. Am J Clin Pathol. 2020; 154(1): 23–32.
- Baergen RN, Heller DS. Placental pathology in COVID-19 positive mothers: preliminary findings. Pediatr Dev Pathol. 2020; 23(3): 177–180.
- Hecht JL, Quade B, Deshpande V, et al. SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers. Mod Pathol. 2020; 33(11): 2092–2103.
- Schwartz DA. An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of sars-cov-2: maternal coronavirus infections and pregnancy outcomes. Arch Pathol Lab Med. 2020; 144(7): 799–805.
- Lu X, Zhang L, Du H, et al. Chinese Pediatric Novel Coronavirus Study Team. SARS-CoV-2 Infection in Children. N Engl J Med. 2020; 382(17): 1663–1665.
- Dugue R, Cay-Martínez KC, Thakur KT, et al. Neurologic manifestations in an infant with COVID-19. Neurology. 2020; 94(24): 1100–1102.
- Kyle MH, Glassman ME, Khan A, et al. A review of newborn outcomes during the COVID-19 pandemic. Semin Perinatol. 2020; 44(7): 151286.
- Carosso A, Cosma S, Borella F, et al. Pre-labor anorectal swab for SARS-CoV-2 in COVID-19 pregnant patients: is it time to think about it? Eur J Obstet Gynecol Reprod Biol. 2020; 249: 98–99.
- Zeng H, Xu C, Fan J, et al. Antibodies in infants born to mothers with COVID-19 pneumonia. JAMA. 2020; 323(18): 1848–1849.
- Leiderman PH, Seashore MJ. Mother-infant neonatal separation: some delayed consequences. Ciba Found Symp. 1975(33): 213–239.
- Oncel MY, Akın IM, Kanburoglu MK, et al. Neo-Covid Study Group. A multicenter study on epidemiological and clinical characteristics of 125 newborns born to women infected with COVID-19 by Turkish Neonatal Society. Eur J Pediatr. 2021; 180(3): 733–742.
